For future consideration of exclusions. Our hospital will sometimes place sickle cell patients on low dose narcan drips (planned) to mitigate severe pruritis and nausea while on narcotics for vaso-occlusive crisis. This is not an adverse event or hospital harm event as it is a planned therapy for the patient but it is showing in the numerator for this measure Perhaps there would be a way to exclude this scenario in the future.